Background Serum thyroid-stimulating hormone (TSH) levels change during body weight reduction. However, the changes that occur during short-term body weight control interventions remain controversial. Thus, this study aimed to evaluate the changes in TSH levels according to body fat reduction.
Methods We performed a 3-month intervention study involving partial meal replacement. Forty-nine participants completed the study. Correlations between changes in TSH levels and other body composition parameters were determined. The subjects were divided into two groups according to their body fat reduction (>1 kg, n=20; <1 kg, n=29). The changes in metabolic parameters, including TSH levels, were compared. For significant values, a multivariate analysis was performed after adjustment to evaluate the relationship between TSH changes and body fat reduction.
Results The 3-month intervention caused favorable changes in body proportions and metabolic parameters. TSH levels changed significantly only after changes in total body fat, showing a partial correlation. Changes in TSH levels were significantly different between groups (P=0.014). Moreover, the change in TSH levels was significantly different after adjustment (P=0.012).
Conclusion A body fat reduction, especially >1 kg, can reduce serum TSH concentrations in subjects with metabolic syndrome after short-term body weight intervention.
Citations
Citations to this article as recorded by
The impact of weight loss interventions on thyroid function: a systematic review and meta-analysis Sandeep Samethadka Nayak, Seyyed Mohammad Hashemi, Masum Patel, Nimra Shafi, Pubali Biswas, Sepide Javankiani, Padmavathi Jaladi, Sanjana B. Patil, Rahiq Rashid, Ehsan Amini-Salehi, Daniyal Ameen, Khushbu Viresh Janani, Anil Kumar Jonnalagadda, Kwame Boat Annals of Medicine & Surgery.2025; 87(7): 4484. CrossRef
Background This double-blind, randomized controlled design study aimed to assess the dose-dependent effects of synbiotics on gastrointestinal symptoms of and fatigue in irritable bowel syndrome (IBS).
Methods Thirty subjects with IBS were randomly assigned into the following three groups and received 2 capsules a day for 8 weeks: (1) high-dose (2 capsules of synbiotics); (2) low-dose (1 capsule of synbiotics and 1 capsule of placebo); and (3) placebo (2 capsules of placebo). At baseline and 8 weeks, they completed the study questionnaires.
Results Two subjects in the high-dose group were lost to follow-up, leaving a total of 28 patients for the analysis. After 8 weeks, abdominal discomfort, abdominal bloating, frequency of formed stool, fatigue Visual Analog Scale (VAS), and Multidimensional Fatigue Inventory were significantly different among the groups (P=0.002, 0.006, 0.007, 0.028, and 0.041, respectively, by Kruskal-Wallis test). However, only abdominal discomfort, abdominal bloating, frequency of formed stool, and fatigue VAS were significantly improved in the high-dose group compared with those in the placebo group (P=0.002, 0.003, 0.002, and 0.013, respectively) by Mann-Whitney test with Bonferroni correction. No adverse drug reactions were reported.
Conclusion High-dose synbiotics were superior to placebo in improving bowel symptoms and fatigue of IBS patients, suggesting that synbiotic dosage plays an important role in the treatment of IBS.
Citations
Citations to this article as recorded by
Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients—A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial Henning Sommermeyer, Krzysztof Chmielowiec, Malgorzata Bernatek, Pawel Olszewski, Jaroslaw Kopczynski, Jacek Piątek Nutrients.2024; 16(10): 1503. CrossRef
The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis Youhe Wu, Yuetong Li, Qi Zheng, Lanjuan Li Nutrients.2024; 16(13): 2114. CrossRef
Synbiotics as Treatment for Irritable Bowel Syndrome: A Review Henning Sommermeyer, Jacek Piątek Microorganisms.2024; 12(7): 1493. CrossRef
The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson’s disease: A double-blind, placebo-controlled, randomized controlled trial Sanaz Mehrabani, Fariborz Khorvash, Zahra Heidari, Maryam Tajabadi-Ebrahimi, Reza Amani Journal of Functional Foods.2023; 100: 105397. CrossRef
Irritable Bowel Syndrome: Treating the Gut and Brain/Mind at the Same Time Maleesha Jayasinghe, John A Damianos, Omesh Prathiraja, Melysze D Oorloff, Gairu M Nagalmulla K, Adithya Nadella, Dilushini Caldera, Ali Mohtashim Cureus.2023;[Epub] CrossRef
The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial Yasaman Khazaei, Ali Basi, Maria Luz Fernandez, Hossein Foudazi, Rafat Bagherzadeh, Farzad Shidfar BMC Complementary Medicine and Therapies.2023;[Epub] CrossRef
The role of gut microbiota in the treatment of irritable bowel syndrome Hamed Ebrahimzadeh Leylabadlo, Fatemah Sadeghpour Heravi, Elghar Soltani, Amin Abbasi, Hossein Samadi Kafil, Mahdi Parsaei, Sarvin Sanaie, Zainab Ahmadian, Reza Ghotaslou Reviews in Medical Microbiology.2022; 33(1): e89. CrossRef
How to Improve Health with Biological Agents—Narrative Review Anna Zawistowska-Rojek, Stefan Tyski Nutrients.2022; 14(9): 1700. CrossRef
Why Use Nutraceutical Strategies for the Irritable Bowel Syndrome? Flavia di Michele Current Medicinal Chemistry.2022; 29(12): 2075. CrossRef
Efficacy of Bifidobacterium breve CECT7263 for infantile colic treatment: an open-label, parallel, randomised, controlled trial J.A. Maldonado-Lobón, R. Blanco-Rojo, J. Maldonado, M.A. Ali, M.V. Almazán, A. Suanes-Cabello, E. Callejón, R. Jaldo, M.R. Benavídes, A.M. Negrillo, A. Sañudo, C. Rodríguez, O. Bañuelos, J. Fonollá, M. Olivares, _ _ Beneficial Microbes.2021; 12(1): 55. CrossRef
Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome Elemer Simon, Lavinia Florina Călinoiu, Laura Mitrea, Dan Cristian Vodnar Nutrients.2021; 13(6): 2112. CrossRef
Evaluation of the Effect of Limosilactobacillus fermentum CECT5716 on Gastrointestinal Infections in Infants: A Systematic Review and Meta-Analysis Belén Pastor-Villaescusa, Ruth Blanco-Rojo, Mónica Olivares Microorganisms.2021; 9(7): 1412. CrossRef
Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review Agnieszka Chlebicz-Wójcik, Katarzyna Śliżewska Biomolecules.2021; 11(8): 1154. CrossRef
The effects of synbiotic supplementation on thyroid function and inflammation in hypothyroid patients: A randomized, double‑blind, placebo‑controlled trial Sepide Talebi, Mozhgan Karimifar, Zahra Heidari, Hamed Mohammadi, Gholamreza Askari Complementary Therapies in Medicine.2020; 48: 102234. CrossRef
Current and emerging pharmacological approaches for treating diarrhea-predominant irritable bowel syndrome Akhil Munjal, Bhavtosh Dedania, Brooks D. Cash Expert Opinion on Pharmacotherapy.2020; 21(1): 63. CrossRef
Irritable Bowel Syndrome and Synbiotics Soo Young Kim Korean Journal of Family Medicine.2019; 40(1): 1. CrossRef
Anti-Inflammatory Diets and Fatigue Ulrike Haß, Catrin Herpich, Kristina Norman Nutrients.2019; 11(10): 2315. CrossRef
Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome Yao Wang, Fengling Zheng, Shan Liu, Huanhuan Luo Gastroenterology Research and Practice.2019; 2019: 1. CrossRef
First
Prev
